Showing 621 - 640 results of 1,766 for search '(( 10 ((we decrease) OR (((mean decrease) OR (a decrease)))) ) OR ( 16 meet decrease ))*', query time: 0.14s Refine Results
  1. 621
  2. 622
  3. 623
  4. 624

    Pd nanocrystals encapsulated in MOF-derived Ni/N-doped hollow carbon nanosheets for efficient thermal CO oxidation: unveiling the effect of porosity by Ipadeola, Adewale K.

    Published 2023
    “…The obtained Pd/Ni-MOF-HNC possesses hollow carbon sheets with a great surface area (153.05 m2 g−1), pore volume (0.12 cm3 g−1), rich Pd/Ni-Nx active sites, Ni-metal defects, rich N-content (7.53 at%), mixed Pd/Ni-oxide phases, and uniformly distributed ultra-small Pd nanocrystals (7.03 ± 1.10 nm); meanwhile, Pd/Ni-MOF-NC formed without etching had no porosity and less Ni-metal defects. …”
    Get full text
    Get full text
    Get full text
  5. 625

    Failure mode analysis for single-phase Multi-level qZSI interfacing PV system to utility grid by Rahman, Syed

    Published 2017
    “…In this paper, control algorithm for the operation of Multi-level qZSI with module failures (up to three modules out of total 16) is discussed. The power deficit due to a failure of the module is reflected as a decrease in the grid current reference. …”
    Get full text
    Get full text
  6. 626

    Wind energy potential along the onshore and offshore Qatar by Mohammed, Aboobacker Valliyil

    Published 2020
    “…cant increase or decrease of wind power around Qatar in the last 40 years in most of the locations, while there is a slight decreasing trend in the o?…”
    Get full text
    Get full text
  7. 627
  8. 628
  9. 629
  10. 630
  11. 631
  12. 632
  13. 633
  14. 634
  15. 635

    Understanding the mechanisms mediating cardio-renal benefit of empagliflozin in type 2 diabetes mellitus by Dimitrios, Patoulias

    Published 2023
    “…They have demonstrated1 that empagliflozin treatment resulted in a significant decrease in pulse pressure (PP), mean arterial pressure (MAP) and cardiac workload, compared with placebo; at week 12, placebo-adjusted mean changes from baseline were − 2.5 mmHg for PP, − 2.2 mmHg for MAP and − 315 mmHg x beats per minute (bpm) for cardiac workload (p < 0.0001 for all). …”
    Get full text
    Get full text
    Get full text
  16. 636
  17. 637
  18. 638
  19. 639
  20. 640